Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

AFT gets greenlight for nine additional European countries

Friday 19 May 2017 09:51 AM

AFT Pharmaceuticals gets greenlight for nine additional European countries

By Rebecca Howard

May 19 (BusinessDesk) - AFT Pharmaceuticals obtained regulatory approval to sell its Maxigesic painkiller in nine additional European countries, a move that lets it ramp up international sales of its tablets.

The Auckland-based drug maker said the European Medicines Agency approved Maxigesic tablets in Austria, Belgium, Croatia, France, Germany, Luxembourg, Netherlands, Portugal and Spain. These countries have been added to the existing European countries where Maxigesic has been approved for sale.

"Collectively they have over US$1.8 billion of annual sales of paracetamol and ibuprofen tablets,” said chief executive Hartley Atkinson. "So approval across most of the EU is a crucial piece of the puzzle for Maxigesic in terms of ramping up international sales and significantly reducing the regulatory risk for Maxigesic tablets."

The EMA’s decision immediately clears the way for Maxigesic product launches in countries where AFT Pharmaceuticals already has a license agreement in place: Belgium, Luxembourg, Spain, Portugal and Ireland. It will add to existing launches in the UK, Italy and a planned launch in the Nordics. The EMA decision is expected to accelerate licensing negotiations in EU countries where agreements are not yet in place.

"We know that for most of the EU, Maxigesic has now been approved, and so we expect to make further progress in reaching licensing agreements in those remaining EU countries in this financial year," said Atkinson.

Earlier this month, AFT said it sold 74 million tablets in the year ended March 31, up from 22 million tablets a year earlier, it said in a statement. The company will report earnings next Wednesday and in March said it expected to generate annual sales of between $69 million and $71 million, up from $65.8 million a year earlier.

The stock last traded at $2.30 and has fallen 25 percent over the past 12 months.

(BusinessDesk)

ends

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Superu Report: Land Regulation Drives Auckland House Prices

Land use regulation is responsible for up to 56 per cent of the cost of an average house in Auckland according to a new research report quantifying the impact of land use regulations, Finance Minister Steven Joyce says. More>>

ALSO:

Fletcher Whittled: Fletcher Dumps Adamson In Face Of Dissatisfaction

Fletcher Building has taken the unusual step of dumping its chief executive, Mark Adamson, as the company slashed its full-year earnings guidance and flagged an impairment against Australian assets. More>>

ALSO:

No More Dog Docking: New Animal Welfare Regulations Progressed

“These 46 regulations include stock transport, farm husbandry, companion and working animals, pigs, layer hens and the way animals are accounted for in research, testing and teaching.” More>>

ALSO:

Employment: Most Kiwifruit Contractors Breaking Law

A Labour Inspectorate operation targeting the kiwifruit industry in Bay of Plenty has found the majority of labour hire contractors are breaching their obligations as employers. More>>

ALSO:

'Work Experience': Welfare Group Opposes The Warehouse Workfare

“This programme is about exploiting unemployed youth, not teaching them skills. The government are subsidising the Warehouse in the name of reducing benefit dependency,” says Vanessa Cole, spokesperson for Auckland Action Against Poverty. More>>

ALSO:

Internet Taxes: Labour To Target $600M In Unpaid Taxes From Multinationals

The Labour Party would target multinationals operating in New Zealand to ensure they don't avoid paying tax if it wins power and is targeting $600 million over three years through a "diverted profits tax," says leader Andrew Little. More>>

ALSO: